Aileron Therapeutics, Inc. (ALRN)
NASDAQ: ALRN · IEX Real-Time Price · USD
0.400
-0.010 (-2.44%)
At close: May 26, 2022 4:00 PM
0.395
-0.005 (-1.250%)
After-hours:May 26, 2022 7:33 PM EDT
Cash Flow Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|
Net Income | -26.16 | -21.16 | -29.37 | -31.55 | -22.6 | -18.12 | -12.88 |
Depreciation & Amortization | 0.12 | 0.16 | 0.16 | 0.22 | 0.13 | 0.23 | 0.33 |
Share-Based Compensation | 2.26 | 1.89 | 2.12 | 3.28 | 1.75 | 0.69 | 0.63 |
Other Operating Activities | 0.03 | -1.38 | 0.62 | 0.12 | 0.2 | 2.19 | 0.22 |
Operating Cash Flow | -23.75 | -20.48 | -26.47 | -27.93 | -20.53 | -15.01 | -11.71 |
Capital Expenditures | -0.09 | 0.2 | -0.15 | -4.42 | -0.14 | 0 | -0.09 |
Change in Investments | -35.83 | 6.21 | -2.66 | 29.11 | -38.77 | 0 | 10.01 |
Other Investing Activities | 0 | 0 | 0 | 0 | 0 | -0.03 | 0.71 |
Investing Cash Flow | -35.92 | 6.41 | -2.81 | 24.69 | -38.91 | -0.03 | 10.63 |
Share Issuance / Repurchase | 55.66 | 15.41 | 23.96 | 0.04 | 50.12 | -0.16 | -1.27 |
Debt Issued / Paid | 0 | 0.39 | 0 | 2.47 | 0 | 0 | 0 |
Other Financing Activities | 0 | 0 | 0 | 0 | 0.47 | 32.14 | -0.09 |
Financing Cash Flow | 55.66 | 15.8 | 23.96 | 2.52 | 50.59 | 31.99 | -1.36 |
Net Cash Flow | -4.01 | 1.74 | -5.32 | -0.72 | -8.85 | 16.95 | -2.44 |
Free Cash Flow | -23.85 | -20.27 | -26.63 | -32.35 | -20.67 | -15.01 | -11.8 |
Free Cash Flow Per Share | -0.27 | -0.58 | -1.08 | -2.19 | -2.78 | -34.94 | -29.46 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).